Literature DB >> 26244810

Large-Scale Identification of N-Glycan Glycoproteins Carrying Lewis x and Site-Specific N-Glycan Alterations in Fut9 Knockout Mice.

Erika Noro1,2, Akira Togayachi1, Takashi Sato1, Azusa Tomioka1, Mika Fujita1, Masako Sukegawa1, Nami Suzuki1, Hiroyuki Kaji1, Hisashi Narimatsu1,2.   

Abstract

The Lewis x (Le(x)) structure (Galβ1-4(Fucα1-3)GlcNAc-R) is a carbohydrate epitope comprising the stage-specific embryonic antigen-1 (SSEA-1) and CD15, and it is synthesized by α1,3-fucosyltransferase 9 (Fut9). Fut9 is expressed specifically in the stomach, kidney, brain, and in leukocytes, suggesting a specific function in these tissues. In this study, the N-linked glycan mass spectrometry profile of wild-type mouse kidney glycoproteins revealed the presence of abundant terminal fucoses, which were lost following knockout of the Fut9 gene; the terminal fucose was therefore concluded to be Le(x). These results suggested that Le(x) presence is widespread rather than being limited to specific proteins. We endeavored to comprehensively identify the Le(x) carriers in the mouse kidney. Glycopeptides carrying fucosylated glycans were collected by Aleuria aurantia lectin (AAL) affinity chromatography from kidney homogenates of wild-type and Fut9 knockout mice. The site-specific N-glycomes on the glycopeptides were subsequently analyzed by adopting a new glycoproteomic technology composed of dissociation-independent assignment of glycopeptide signals and accurate mass-based prediction of the N-glycome on the glycopeptides. Our analyses demonstrated that 24/32 glycoproteins contained the Le(x) N-glycan structure in wild-type kidney; of these, Le(x) was lost from 21 in the knockout mice. This is the first report of large-scale identification of Le(x)-carrying glycoproteins from a native sample based on the site-specific glycome analysis.

Entities:  

Keywords:  IGOT-LC−MS; Lewis x; glycoproteomics; kidney; knockout mouse; site-specific N-glycome analysis; α1,3-fucosyltransferase 9 (Fut9)

Mesh:

Substances:

Year:  2015        PMID: 26244810     DOI: 10.1021/acs.jproteome.5b00178

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  14 in total

Review 1.  Maturing Glycoproteomics Technologies Provide Unique Structural Insights into the N-glycoproteome and Its Regulation in Health and Disease.

Authors:  Morten Thaysen-Andersen; Nicolle H Packer; Benjamin L Schulz
Journal:  Mol Cell Proteomics       Date:  2016-02-29       Impact factor: 5.911

2.  Enhanced Neuronal Survival and Neurite Outgrowth Triggered by Novel Small Organic Compounds Mimicking the LewisX Glycan.

Authors:  Thomas Theis; Anmol Singh Johal; Maciej Kabat; Sayantani Basak; Melitta Schachner
Journal:  Mol Neurobiol       Date:  2018-03-08       Impact factor: 5.590

3.  Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.

Authors:  Atsushi Matsuda; Michiyo Higashi; Tomomi Nakagawa; Seiya Yokoyama; Atsushi Kuno; Suguru Yonezawa; Hisashi Narimatsu
Journal:  Lab Invest       Date:  2017-06-05       Impact factor: 5.662

Review 4.  Global and site-specific analysis of protein glycosylation in complex biological systems with Mass Spectrometry.

Authors:  Haopeng Xiao; Fangxu Sun; Suttipong Suttapitugsakul; Ronghu Wu
Journal:  Mass Spectrom Rev       Date:  2019-01-03       Impact factor: 10.946

Review 5.  Mass Spectrometry Approaches to Glycomic and Glycoproteomic Analyses.

Authors:  L Renee Ruhaak; Gege Xu; Qiongyu Li; Elisha Goonatilleke; Carlito B Lebrilla
Journal:  Chem Rev       Date:  2018-03-19       Impact factor: 60.622

6.  Quantitative capillary zone electrophoresis-mass spectrometry reveals the N-glycome developmental plan during vertebrate embryogenesis.

Authors:  Yanyan Qu; Kyle M Dubiak; Elizabeth H Peuchen; Matthew M Champion; Zhenbin Zhang; Alex S Hebert; Sarah Wright; Joshua J Coon; Paul W Huber; Norman J Dovichi
Journal:  Mol Omics       Date:  2020-06-15

7.  A vital sugar code for ricin toxicity.

Authors:  Jasmin Taubenschmid; Johannes Stadlmann; Markus Jost; Tove Irene Klokk; Cory D Rillahan; Andreas Leibbrandt; Karl Mechtler; James C Paulson; Julian Jude; Johannes Zuber; Kirsten Sandvig; Ulrich Elling; Thorsten Marquardt; Christian Thiel; Christian Koerner; Josef M Penninger
Journal:  Cell Res       Date:  2017-09-19       Impact factor: 25.617

8.  Inhibition of fucosylation by 2-fluorofucose suppresses human liver cancer HepG2 cell proliferation and migration as well as tumor formation.

Authors:  Ying Zhou; Tomohiko Fukuda; Qinglei Hang; Sicong Hou; Tomoya Isaji; Akihiko Kameyama; Jianguo Gu
Journal:  Sci Rep       Date:  2017-09-14       Impact factor: 4.379

9.  A standardized method for lectin microarray-based tissue glycome mapping.

Authors:  Xia Zou; Maki Yoshida; Chiaki Nagai-Okatani; Jun Iwaki; Atsushi Matsuda; Binbin Tan; Kozue Hagiwara; Takashi Sato; Yoko Itakura; Erika Noro; Hiroyuki Kaji; Masashi Toyoda; Yan Zhang; Hisashi Narimatsu; Atsushi Kuno
Journal:  Sci Rep       Date:  2017-03-06       Impact factor: 4.379

10.  Inhibition of fucosylation in human invasive ductal carcinoma reduces E-selectin ligand expression, cell proliferation, and ERK1/2 and p38 MAPK activation.

Authors:  Mylène A Carrascal; Mariana Silva; José S Ramalho; Cláudia Pen; Manuela Martins; Carlota Pascoal; Constança Amaral; Isabel Serrano; Maria José Oliveira; Robert Sackstein; Paula A Videira
Journal:  Mol Oncol       Date:  2018-03-30       Impact factor: 6.603

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.